Elevated expression of SPP1 has been observed in multiple cancers, including colon cancer, lung cancer, prostate cancer, breast cancer, ovarian cancer, multiple myeloma, acute myeloid leukaemia, and chronic myeloid leukaemia [25–27]. This evidence concerns the gene SPP1 and chronic myelogenous leukemia, BCR-ABL1 positive.